Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.

The American journal of surgical pathology - 1 May 2015

Martinez-Lopez Azahara, Curiel-Olmo Soraya, Mollejo Manuela, Cereceda Laura, Martinez Nerea, Montes-Moreno Santiago, Almaraz Carmen, Revert Jose B, Piris Miguel A

Abstract excerpt

MYD88 L265P is a somatic mutation that has been identified in about 90% of Waldenström macroglobulinemia/lymphoplasmacytic lymphomas (LPLs). It has also been detected in a subset of marginal zone lymphoma (MZL) cases, but the frequency and clinical and histologic features of these mutated MZL cases has only been partially characterized. We have developed a customized TaqMan allele-specific polymerase chain...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Lymphoma, B-Cell, Marginal Zone

Share to Mutation

Share to Myeloid Differentiation Factor 88

Share to Polymerase Chain Reaction

Share to Waldenstrom Macroglobulinemia

Source

Identifiers

PMID: 25723115
DOI: 10.1097/PAS.0000000000000411

Genes

MYD88
LPL

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.PMID 25723115Read ↗

A Somatic Variant in MYD88 (L265P) Revealed by Whole Genome Sequencing Differentiates Lymphoplasmacytic Lymphoma From Marginal Zone LymphomasSemantic proximity Read ↗

Detection of MYD88 L265P mutations in formalin-fixed and decalcified BM biopsies from patients with lymphoplasmacytic lymphoma.Semantic proximity Read ↗

Significance of MYD88 L265P Mutation Status in the Subclassification of Low-Grade B-Cell Lymphoma/Leukemia.Semantic proximity Read ↗

Detection of L265P MYD-88 mutation in a series of clonal B-cell lymphocytosis of marginal zone origin (CBL-MZ).Semantic proximity Read ↗

MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.Semantic proximity Read ↗

MYD88 L265P Somatic MutationSemantic proximity Read ↗

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.Semantic proximity Read ↗

Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?Semantic proximity Read ↗

IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.Semantic proximity Read ↗

MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.Semantic proximity Read ↗

MYD88 Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies.Semantic proximity Read ↗

Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.